What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Thrombosis
His main research concerns Surgery, Thrombosis, Anticoagulant, Pulmonary embolism and Venous thrombosis.
He usually deals with Surgery and limits it to topics linked to Internal medicine and Gastroenterology.
The concepts of his Thrombosis study are interwoven with issues in First episode, Radiology and Risk factor.
His Anticoagulant research is multidisciplinary, incorporating perspectives in Heparin, Chemoprophylaxis, Clinical trial and Warfarin.
His biological study spans a wide range of topics, including Anesthesia, Chemotherapy, Randomization and Hazard ratio.
The Post-thrombotic syndrome research Jeffrey S. Ginsberg does as part of his general Venous thrombosis study is frequently linked to other disciplines of science, such as Grading, therefore creating a link between diverse domains of science.
His most cited work include:
- Derivation of a Simple Clinical Model to Categorize Patients Probability of Pulmonary Embolism: Increasing the Models Utility with the SimpliRED D-dimer (1148 citations)
- A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. (1054 citations)
- A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. (935 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Surgery, Thrombosis, Internal medicine, Venous thrombosis and Deep vein.
Jeffrey S. Ginsberg combines subjects such as Anesthesia and Warfarin with his study of Surgery.
His work carried out in the field of Thrombosis brings together such families of science as Pulmonary embolism, Radiology, Vascular disease and Vein.
His research integrates issues of Gastroenterology and Cardiology in his study of Internal medicine.
His Venous thrombosis research is multidisciplinary, incorporating elements of Incidence, Cohort study, First episode, Anticoagulant therapy and Risk factor.
Jeffrey S. Ginsberg has included themes like Antithrombotic, Chemoprophylaxis, Low molecular weight heparin, Heparin and Intensive care medicine in his Anticoagulant study.
He most often published in these fields:
- Surgery (48.58%)
- Thrombosis (41.60%)
- Internal medicine (29.20%)
What were the highlights of his more recent work (between 2011-2021)?
- Surgery (48.58%)
- Internal medicine (29.20%)
- Thrombosis (41.60%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Surgery, Internal medicine, Thrombosis, Randomized controlled trial and Anesthesia.
Surgery is closely attributed to Quartile in his work.
Jeffrey S. Ginsberg focuses mostly in the field of Internal medicine, narrowing it down to topics relating to Cardiology and, in certain cases, Heparinoid.
His Thrombosis study deals with Radiology intersecting with Venography, Vein and Lower limbs venous ultrasonography.
His work deals with themes such as Observational study, Placebo and Medical education, which intersect with Randomized controlled trial.
His Pulmonary embolism study integrates concerns from other disciplines, such as Venous thromboembolism, Retrospective cohort study and D-dimer.
Between 2011 and 2021, his most popular works were:
- Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial. (305 citations)
- The Postthrombotic Syndrome: Evidence-Based Prevention, Diagnosis, and Treatment Strategies A Scientific Statement From the American Heart Association (279 citations)
- D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study (93 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Thrombosis
Thrombosis, Surgery, Internal medicine, Venous thrombosis and Prospective cohort study are his primary areas of study.
Jeffrey S. Ginsberg works on Thrombosis which deals in particular with Deep vein.
His work in Surgery is not limited to one particular discipline; it also encompasses Placebo.
Jeffrey S. Ginsberg interconnects Anesthesia, Clinical trial, Randomized controlled trial, Family medicine and D-dimer in the investigation of issues within Venous thrombosis.
Jeffrey S. Ginsberg has researched Clinical trial in several fields, including Anticoagulant and Atrial fibrillation, Warfarin.
His Prospective cohort study research includes elements of Quartile and Blood coagulation test.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
